Machine learning to predict mortality for aneurysmal subarachnoid hemorrhage (aSAH) using a large nationwide EHR database
| Published in: | PLOS Digital Health |
|---|---|
| Main Authors: | Gen Zhu, Anthony Yuan, Duo Yu, Alicia Zha, Hulin Wu |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-12-01
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10699620/?tool=EBI |
Similar Items
Machine learning to predict mortality for aneurysmal subarachnoid hemorrhage (aSAH) using a large nationwide EHR database.
by: Gen Zhu, et al.
Published: (2023-12-01)
by: Gen Zhu, et al.
Published: (2023-12-01)
Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH)
by: Kathleen R Ran, et al.
Published: (2023-03-01)
by: Kathleen R Ran, et al.
Published: (2023-03-01)
Gelsolin: A Promising Biomarker for Aneurysmal Subarachnoid Hemorrhage (aSAH)
by: Dr. Chao-ya Yang, et al.
Published: (2025-01-01)
by: Dr. Chao-ya Yang, et al.
Published: (2025-01-01)
Predicting Clinical Outcome And In Hospital Mortality After Aneurysmal Subarachnoid Hemorrhage (aSAH) With OLINK Proteomics Biomarkers
by: Dr. Dilaware Khan, et al.
Published: (2025-01-01)
by: Dr. Dilaware Khan, et al.
Published: (2025-01-01)
Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom
by: Gray Alastair, et al.
Published: (2010-04-01)
by: Gray Alastair, et al.
Published: (2010-04-01)
Predicting Post-Hemorrhagic Hydrocephalus and Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage (aSAH) Using OLINK-Proteomics
by: Mr Sihmehmet Sahan, et al.
Published: (2025-01-01)
by: Mr Sihmehmet Sahan, et al.
Published: (2025-01-01)
Systemic Platelet Factor 4 (PF4) And Stromal Cell-Derived Factor 1 (SDF1) Predicted Post Aneurysmal Subarachnoid Hemorrhage (aSAH) Complications And In Hospital Mortality After aSAH
by: Mr Sihmehmet Sahan, et al.
Published: (2025-01-01)
by: Mr Sihmehmet Sahan, et al.
Published: (2025-01-01)
Long-Term Quality of Life and Depressive Symptoms in Survivors after Poor-Grade Aneurysmal Subarachnoid Hemorrhage (aSAH)
by: Ms Isabel David, et al.
Published: (2025-01-01)
by: Ms Isabel David, et al.
Published: (2025-01-01)
The predictive role of family history of antipsychotic drug use in poor outcomes following aneurysmal subarachnoid hemorrhage (aSAH)
by: Juho Paavola, et al.
Published: (2025-01-01)
by: Juho Paavola, et al.
Published: (2025-01-01)
Pencegahan Terjadinya Delayed Cerebral Ischemia (DCI) pada Pasien Aneurysmal Subarachnoid Hemorrhage (aSAH) di Intensive Care Unit
by: Daryanto Tri Winarko, et al.
Published: (2020-03-01)
by: Daryanto Tri Winarko, et al.
Published: (2020-03-01)
Evaluation of MTT Heterogeneity of Perfusion CT Imaging in the Early Brain Injury Phase: An Insight into aSAH Pathopysiology
by: Björn B. Hofmann, et al.
Published: (2023-05-01)
by: Björn B. Hofmann, et al.
Published: (2023-05-01)
Massive traumatic subarachnoid hemorrhage mimicking aneurysmal subarachnoid hemorrhage
by: Amr Rachid El Mohamad, et al.
Published: (2023-12-01)
by: Amr Rachid El Mohamad, et al.
Published: (2023-12-01)
Lactate dehydrogenase predicting mortality in patients with aneurysmal subarachnoid hemorrhage
by: Xin Zan, et al.
Published: (2022-10-01)
by: Xin Zan, et al.
Published: (2022-10-01)
Magnesium Monotherapy vs. Nimodipine Monotherapy for Preventing Delayed Cerebral Infarction After aSAH: A Matched Cohort Study
by: Ms Katharina Mehling, et al.
Published: (2025-01-01)
by: Ms Katharina Mehling, et al.
Published: (2025-01-01)
Re-evaluating methodological approaches in assessing psychiatric history and outcomes post-aSAH: A commentary on Paavola et al.
by: Manahil Ikhlaque, et al.
Published: (2025-01-01)
by: Manahil Ikhlaque, et al.
Published: (2025-01-01)
Interrelationships Between Inflammatory Score, Delayed Cerebral Ischemia and Unfavorable Outcome in Patients with aSAH: A Four-Way Decomposition
by: Zhang P, et al.
Published: (2024-12-01)
by: Zhang P, et al.
Published: (2024-12-01)
Evaluation of Mean Transit Time Heterogeneity of Perfusion CT Imaging in the Early Brain Injury Phase: An Insight into aSAH Pathophysiology
by: Björn Hofmann, et al.
Published: (2023-01-01)
by: Björn Hofmann, et al.
Published: (2023-01-01)
Clinical Pharmacology of Clazosentan, a Selective Endothelin A Receptor Antagonist for the Prevention and Treatment of aSAH-Related Cerebral Vasospasm
by: Pierre-Eric Juif, et al.
Published: (2021-02-01)
by: Pierre-Eric Juif, et al.
Published: (2021-02-01)
Association of albumin to globulin ratio with mortality in patients with aneurysmal subarachnoid hemorrhage.
by: Yangchun Xiao, et al.
Published: (2025-01-01)
by: Yangchun Xiao, et al.
Published: (2025-01-01)
Predictors of Intrahospital Mortality in Aneurysmal Subarachnoid Hemorrhage after Endovascular Embolization
by: Valentina Opancina, et al.
Published: (2024-07-01)
by: Valentina Opancina, et al.
Published: (2024-07-01)
Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH)
by: Rebecca Heinz, et al.
Published: (2021-01-01)
by: Rebecca Heinz, et al.
Published: (2021-01-01)
Current Management of Aneurysmal Subarachnoid Hemorrhage
by: Jay Max Findlay
Published: (2025-02-01)
by: Jay Max Findlay
Published: (2025-02-01)
Subarachnoid hemorrhage after aneurysm surgery
by: Carlos Gilberto Carlotti Junior, et al.
Published: (1996-06-01)
by: Carlos Gilberto Carlotti Junior, et al.
Published: (1996-06-01)
Risk factors and outcomes after interruption of sedation in subarachnoid hemorrhage (ROUTINE-SAH)—a retrospective cohort study
by: Moritz L. Schmidbauer, et al.
Published: (2024-03-01)
by: Moritz L. Schmidbauer, et al.
Published: (2024-03-01)
Machine learning algorithm to predict in-hospital mortality after aneurysmal subarachnoid hemorrhage
by: Juri V. Kivelev, et al.
Published: (2024-12-01)
by: Juri V. Kivelev, et al.
Published: (2024-12-01)
The impact of subarachnoid and ventricular hemorrhage extension on ventriculostomy-related infections in patients with aneurysmal subarachnoid hemorrhage
by: Florian Marc Ebel, et al.
Published: (2023-01-01)
by: Florian Marc Ebel, et al.
Published: (2023-01-01)
Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage
by: Bosco Seong Kyu Yang, et al.
Published: (2025-01-01)
by: Bosco Seong Kyu Yang, et al.
Published: (2025-01-01)
Aneurysmal subarachnoid hemorrhage: current concepts and updates
by: Carolina Rouanet, et al.
Published: (2019-12-01)
by: Carolina Rouanet, et al.
Published: (2019-12-01)
Effect of Aneurysmal Subarachnoid Hemorrhage on Word Generation
by: Daniella Ladowski, et al.
Published: (2014-01-01)
by: Daniella Ladowski, et al.
Published: (2014-01-01)
Return to work after aneurysmal subarachnoid hemorrhage
by: Angelika Sorteberg, et al.
Published: (2024-04-01)
by: Angelika Sorteberg, et al.
Published: (2024-04-01)
Aneurysmal Versus “Benign” Perimesencephalic Subarachnoid Hemorrhage
by: Anas Alrohimi, et al.
Published: (2024-05-01)
by: Anas Alrohimi, et al.
Published: (2024-05-01)
Pituitary Hormonal Disturbances in Aneurysmal Subarachnoid Hemorrhage
by: Jose Carlos de Moura, et al.
Published: (2023-06-01)
by: Jose Carlos de Moura, et al.
Published: (2023-06-01)
Several Risk Factors for Aneurysmal Subarachnoid Hemorrhage
by: Pavel G. Shnyakin, et al.
Published: (2023-06-01)
by: Pavel G. Shnyakin, et al.
Published: (2023-06-01)
Fasudil hydrochloride and ozagrel sodium combination therapy for patients with aneurysmal subarachnoid hemorrhage: a cross-sectional study using a nationwide inpatient database
by: Hiroshi Magara, et al.
Published: (2024-08-01)
by: Hiroshi Magara, et al.
Published: (2024-08-01)
Association between neutrophil-to-albumin ratio and long-term mortality of aneurysmal subarachnoid hemorrhage
by: Renjie Zhang, et al.
Published: (2023-10-01)
by: Renjie Zhang, et al.
Published: (2023-10-01)
Adverse events during endovascular treatment of ruptured aneurysms: A prospective nationwide study on subarachnoid hemorrhage in Sweden
by: Bryndís Baldvinsdóttir, et al.
Published: (2023-01-01)
by: Bryndís Baldvinsdóttir, et al.
Published: (2023-01-01)
Comment on shortened treatment with nimodipine in aneurysmal subarachnoid hemorrhage
by: Begoña Guardiola, et al.
Published: (2025-01-01)
by: Begoña Guardiola, et al.
Published: (2025-01-01)
The role of neutrophil-related indicators in aneurysmal subarachnoid hemorrhage
by: Qi Tian, et al.
Published: (2025-10-01)
by: Qi Tian, et al.
Published: (2025-10-01)
Immunoglobulin A vasculitis with aneurysmal subarachnoid hemorrhage in an adult
by: Priya Patel Housley, MS, et al.
Published: (2025-11-01)
by: Priya Patel Housley, MS, et al.
Published: (2025-11-01)
Clazosentan for aneurysmal subarachnoid hemorrhage: Update from Japan
by: Hidenori Suzuki, et al.
Published: (2025-10-01)
by: Hidenori Suzuki, et al.
Published: (2025-10-01)
Similar Items
-
Machine learning to predict mortality for aneurysmal subarachnoid hemorrhage (aSAH) using a large nationwide EHR database.
by: Gen Zhu, et al.
Published: (2023-12-01) -
Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH)
by: Kathleen R Ran, et al.
Published: (2023-03-01) -
Gelsolin: A Promising Biomarker for Aneurysmal Subarachnoid Hemorrhage (aSAH)
by: Dr. Chao-ya Yang, et al.
Published: (2025-01-01) -
Predicting Clinical Outcome And In Hospital Mortality After Aneurysmal Subarachnoid Hemorrhage (aSAH) With OLINK Proteomics Biomarkers
by: Dr. Dilaware Khan, et al.
Published: (2025-01-01) -
Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom
by: Gray Alastair, et al.
Published: (2010-04-01)
